Alendronate Sodium Tablets

This contract has been awarded

Awarded to Exelan Pharmaceuticals Inc (FL) for up to $4.5M (IDIQ ceiling) on Mar 19, 2026. That's the most the contract can be worth, not what will be paid. Award number SPE2D2-26-D-0009.

Recent DLA contract awards: who won →

These similar contracts are still open:

• Sacubitril/Valsartan Tablets (VA-27-00014055)Department of Veterans Affairs · Due Nov 3, 2026This is a presolicitation: the Department of Veterans Affairs (VA) Enterprise Procurement Office plans to issue a request for proposals (RFP) for sacubitril-valsartan tablets on…
• FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052Department of Veterans Affairs · Cleveland and Kent, OH · Due Nov 3, 2026Sources sought (market research only, not a solicitation): the Veterans Affairs Network Contract Office 10 wants to find firms that can supply unit-dose low energy…
• Lidocaine 5% Patches-Request for InformationDepartment of Veterans Affairs · KS · Due Nov 3, 2026The Department of Veterans Affairs (VA) National CMOP Office is doing market research for L0515: Lidocaine 5% Patches, box of 30.
• TECHNOLOGY LICENSING OPPORTUNITY: Clathrate Therapeutics PlatformDepartment of Energy · Los Alamos, NM · Due Dec 3, 2026
• Methylphenidate ERDepartment of Defense · Defense Logistics Agency · Due Nov 6, 2026DLA Troop Support (Defense Logistics Agency) wants one national supplier of methylphenidate extended-release tablets in four strengths, in 100-count bottles.

See every open contract under NAICS 325412